EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC0

Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study

Donald S Grant, Emily J Engel iD, Nicole Roberts Yerkes, Lansana Kanneh, James Koninga, Michael A Gbakie, Foday Alhasan, Franklyn B Kanneh, Ibrahim Mustapha Kanneh, Fatima K Kamara, Mambu Momoh, Mohamed S Yillah und 20 weitere

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0010938 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Donald S Grant und 31 weiteren Autor:innen. Beteiligte Einrichtung: Lassa Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone. Hauptthemen laut MEDLINE: Lassa Fever, Virus Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, United States Agency for International Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Lassa virus (LASV), the cause of the acute viral hemorrhagic illness Lassa fever (LF), is endemic in West Africa. Infections in humans occur mainly after exposure to infected excrement or urine of the rodent-host, Mastomys natalensis . The prevalence of exposure to LASV in Sierra Leone is crudely estimated and largely unknown. This cross-sectional study aimed to establish a baseline point seroprevalence of IgG antibodies to LASV in three administrative districts of Sierra Leone and identify potential risk factors for seropositivity and LASV exposure. Methodology and principal findings Between 2015 and 2018, over 10,642 participants from Kenema, Tonkolili, and Port Loko Districts were enrolled in this cross-sectional study. Previous LASV and LF epidemiological studies support classification of these districts as “endemic,” “emerging,” and “non-endemic”, respectively. Dried blood spot samples were tested for LASV antibodies by ELISA to determine the seropositivity of participants, indicating previous exposure to LASV. Surveys were administered to each participant to assess demographic and environmental factors associated with a higher risk of exposure to LASV. Overall seroprevalence for antibodies to LASV was 16.0%. In Kenema, Port Loko, and Tonkolili Districts, seroprevalences were 20.1%, 14.1%, and 10.6%, respectively. In a multivariate analysis, individuals were more likely to be LASV seropositive if they were living in Kenema District, regardless of sex, age, or occupation. Environmental factors contributed to an increased risk of LASV exposure, including poor housing construction and proximity to bushland, forested areas, and refuse. Conclusions and significance In this study we determine a baseline LASV seroprevalence in three districts which will inform future epidemiological, ecological, and clinical studies on LF and the LASV in Sierra Leone. The heterogeneity of the distribution of LASV and LF over both space, and time, can make the design of efficacy trials and intervention programs difficult. Having more studies on the prevalence of LASV and identifying potential hyper-endemic areas will greatly increase the awareness of LF and improve targeted control programs related to LASV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa FeverVirus DiseasesAnimalsHumansSierra LeoneCross-Sectional StudiesSeroepidemiologic StudiesLassa virusMurinaeAntibodies, ViralImmunoglobulin G

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Lassa Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
  • College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
  • Department of Pediatrics, Sections of Pediatric Infectious Diseases, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
  • Eastern Technical University of Sierra Leone, Kenema, Sierra Leone.
  • Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States of America.
  • Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.

ORCID-Profile: Emily J Engel

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • United States Agency for International Development

Zitieren

APA

Grant, D. S., Engel, E. J., Roberts Yerkes, N., Kanneh, L., Koninga, J., Gbakie, M. A., Alhasan, F., Kanneh, F. B., Kanneh, I. M., Kamara, F. K., Momoh, M., Yillah, M. S., Foday, M., Okoli, A., Zeoli, A., Weldon, C., Bishop, C. M., Zheng, C., Hartnett, J., …, & Schieffelin, J. S. (2023). Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0010938

Vancouver

Grant DS, Engel EJ, Roberts Yerkes N, Kanneh L, Koninga J, Gbakie MA, et al. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0010938

BibTeX
@article{Grant2023,
  author = {Grant, Donald S and Engel, Emily J and Roberts Yerkes, Nicole and Kanneh, Lansana and Koninga, James and Gbakie, Michael A and Alhasan, Foday and Kanneh, Franklyn B and Kanneh, Ibrahim Mustapha and Kamara, Fatima K and Momoh, Mambu and Yillah, Mohamed S and Foday, Momoh and Okoli, Adaora and Zeoli, Ashley and Weldon, Caroline and Bishop, Christopher M and Zheng, Crystal and Hartnett, Jessica and Chao, Karissa and Shore, Kayla and Melnik, Lilia I and Mucci, Mallory and Bond, Nell G and Doyle, Philip and Yenni, Rachael and Podgorski, Rachel and Ficenec, Samuel C and Moses, Lina and Shaffer, Jeffrey G and Garry, Robert F and Schieffelin, John S},
  title = {Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0010938}
}
Kostenlos starten →